MAIA Biotechnology Files 8-K
Ticker: MAIA · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1878313
Sentiment: neutral
Topics: 8-K, filing, financials
TL;DR
MAIA Bio filed an 8-K on June 18th, likely with financial updates.
AI Summary
On June 18, 2025, MAIA Biotechnology, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and significant occurrences. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This filing signals that MAIA Biotechnology, Inc. is providing updates to the SEC, which could contain important information for investors regarding the company's operations or financial health.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report without immediate disclosure of negative events or significant financial changes.
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- June 18, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-41455 (commission_file_number) — SEC File Number
- 444 West Lake Street, Suite 1700 (address) — Principal executive offices
- Chicago, IL (location) — City and State of principal executive offices
- 60606 (zip_code) — Zip code of principal executive offices
- (312) 416-8592 (phone_number) — Registrant's telephone number
FAQ
What specific "Other Events" are being reported by MAIA Biotechnology, Inc. on June 18, 2025?
The provided excerpt of the 8-K filing does not detail the specific "Other Events" being reported, only that this item is included in the filing.
What is the nature of the "Financial Statements and Exhibits" being filed?
The excerpt indicates that "Financial Statements and Exhibits" are part of the filing, but does not specify their content or purpose.
What is MAIA Biotechnology, Inc.'s principal executive office address?
MAIA Biotechnology, Inc.'s principal executive offices are located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.
What is the SEC File Number for MAIA Biotechnology, Inc.?
The SEC File Number for MAIA Biotechnology, Inc. is 001-41455.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on June 18, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding MAIA Biotechnology, Inc. (MAIA).